Bryce Point Capital LLC bought a new position in HCA Healthcare, Inc. (NYSE:HCA – Free Report) during the 4th quarter, HoldingsChannel reports. The fund bought 1,479 shares of the company’s stock, valued at approximately $444,000.
Several other institutional investors have also recently added to or reduced their stakes in the company. Congress Wealth Management LLC DE boosted its holdings in shares of HCA Healthcare by 3.4% in the 4th quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company’s stock worth $312,000 after acquiring an additional 34 shares in the last quarter. Evergreen Private Wealth LLC grew its holdings in shares of HCA Healthcare by 0.3% during the fourth quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company’s stock worth $3,838,000 after purchasing an additional 35 shares during the last quarter. Mediolanum International Funds Ltd raised its holdings in shares of HCA Healthcare by 0.3% in the fourth quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company’s stock valued at $3,153,000 after buying an additional 36 shares during the last quarter. Prairie Wealth Advisors Inc. grew its holdings in HCA Healthcare by 6.1% during the 4th quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company’s stock worth $210,000 after acquiring an additional 40 shares during the last quarter. Finally, Whittier Trust Co. lifted its position in shares of HCA Healthcare by 3.6% during the fourth quarter. Whittier Trust Co. now owns 1,195 shares of the company’s stock worth $359,000 after purchasing an additional 41 shares in the last quarter. 62.73% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Several research firms recently weighed in on HCA. Royal Bank of Canada dropped their price objective on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a research report on Monday, January 27th. Truist Financial lowered their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, January 6th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $380.00 target price on shares of HCA Healthcare in a research note on Tuesday, December 17th. Barclays cut their price objective on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a report on Monday, January 27th. Finally, KeyCorp dropped their target price on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $385.67.
HCA Healthcare Stock Down 4.8 %
Shares of HCA stock opened at $332.53 on Friday. The company has a market capitalization of $81.87 billion, a price-to-earnings ratio of 15.14, a P/E/G ratio of 1.10 and a beta of 1.68. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The firm has a fifty day moving average of $327.23 and a 200-day moving average of $339.87.
HCA Healthcare (NYSE:HCA – Get Free Report) last posted its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the previous year, the company earned $5.90 earnings per share. As a group, equities research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.
HCA Healthcare Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Monday, March 17th were paid a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.87%. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date was Monday, March 17th. HCA Healthcare’s dividend payout ratio is currently 13.11%.
Insider Activity at HCA Healthcare
In other news, SVP Jennifer Berres sold 9,533 shares of the company’s stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the sale, the senior vice president now owns 15,412 shares in the company, valued at $4,971,757.08. This represents a 38.22 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. 1.30% of the stock is owned by company insiders.
HCA Healthcare Profile
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Read More
- Five stocks we like better than HCA Healthcare
- How to Invest in Small Cap Stocks
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- Consumer Discretionary Stocks Explained
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- How to Find Undervalued Stocks
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.